Furthermore, multidrug resistance-associated protein 2 (MRP2) could efflux glutathione conjugates of cisplatin from cancer cells, therefore conferring cytotoxicity resistance34, 35, 36 and protecting kidneys from cisplatin nephrotoxicity by reducing the burden of tubular cells37. This evidence concerns the gene ABCC2 and cancer.